Gene-activated matrix combined with a bone transcriptional factor, Cbfa1 that induce bone formation may be a key advancement in treating bone loss due to periodontal diseases, trauma, or congenital disorders, researchers say. These results were recently published in Wound Repair and Regeneration, Volume 15, June 2007. [click link for full article]
More: continued here
